Amit Gupta - 16 Aug 2025 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Signature
/s/ Nick Lynton, Attorney-in-Fact
Issuer symbol
CDLX
Transactions as of
16 Aug 2025
Net transactions value
-$153,582
Form type
4
Filing time
19 Aug 2025, 18:44:00 UTC
Previous filing
02 Jul 2025
Next filing
02 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gupta Amit Chief Executive Officer, Director 675 PONCE DE LEON AVENUE NE, SUITE 4100, ATLANTA /s/ Nick Lynton, Attorney-in-Fact 19 Aug 2025 0001961238

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Options Exercise +125,000 +33% 503,704 18 Aug 2025 Direct F1
transaction CDLX Common Stock Options Exercise +125,000 +25% 628,704 18 Aug 2025 Direct F1
transaction CDLX Common Stock Sale $76,792 -68,260 -11% $1.12 560,444 18 Aug 2025 Direct F2, F3
transaction CDLX Common Stock Sale $76,790 -68,685 -12% $1.12 491,759 19 Aug 2025 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Restricted Stock Units Options Exercise $0 -125,000 -33% $0.000000 250,000 16 Aug 2025 Common Stock 125,000 Direct F1, F5
transaction CDLX Restricted Stock Units Options Exercise $0 -125,000 -33% $0.000000 250,000 16 Aug 2025 Common Stock 125,000 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F2 Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on August 18, 2025. The Reporting Person did not sell shares for any other purpose.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.075 to $1.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (3) and (4) in this Form 4.
F4 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.085 to $1.155, inclusive.
F5 The RSU award is for 500,000 shares that were granted on August 21, 2024. The RSUs will vest and have vested in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date.
F6 The RSU award is for 500,000 shares that were granted on January 29, 2025. The RSUs will vest in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date.